EP 3938395 A1 20220119 - PHARMACEUTICAL COMPOSITIONS CONTAINING ANTI-LINGO-1 ANTIBODIES
Title (en)
PHARMACEUTICAL COMPOSITIONS CONTAINING ANTI-LINGO-1 ANTIBODIES
Title (de)
PHARMAZEUTISCHE ZUSAMMENSETZUNGEN MIT ANTI-LINGO-1-ANTIKÖRPERN
Title (fr)
COMPOSITIONS PHARMACEUTIQUES CONTENANT DES ANTICORPS ANTI-LINGO-1
Publication
Application
Priority
- US 201962816668 P 20190311
- US 201962817323 P 20190312
- US 2020021842 W 20200310
Abstract (en)
[origin: WO2020185750A1] Pharmaceutical compositions containing anti-LINGO-1 antibodies or LINGO-1-binding fragments thereof are provided. These pharmaceutical compositions find use in the treatment of CNS demyelinating diseases, such as multiple sclerosis and optic neuritis (e.g., acute optic neuritis).
IPC 8 full level
C07K 16/28 (2006.01); A61K 9/08 (2006.01); A61K 39/00 (2006.01); A61K 39/395 (2006.01); A61K 47/18 (2017.01); A61P 25/28 (2006.01)
CPC (source: EP IL KR US)
A61K 9/0019 (2013.01 - EP IL KR); A61K 9/08 (2013.01 - EP IL KR); A61K 39/395 (2013.01 - EP IL KR); A61K 47/183 (2013.01 - EP IL KR US); A61K 47/20 (2013.01 - KR); A61K 47/22 (2013.01 - KR); A61K 47/26 (2013.01 - KR US); A61K 47/34 (2013.01 - EP IL); A61P 25/28 (2018.01 - EP IL KR); C07K 16/2803 (2013.01 - EP IL KR US); A61K 2039/505 (2013.01 - EP IL KR US); A61K 2039/54 (2013.01 - EP IL); A61K 2039/545 (2013.01 - EP IL US); C07K 2317/90 (2013.01 - EP IL); C07K 2317/94 (2013.01 - EP IL KR)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2020185750 A1 20200917; AU 2020234943 A1 20210923; BR 112021017644 A2 20211116; CA 3133072 A1 20200917; CN 113661179 A 20211116; EP 3938395 A1 20220119; IL 286162 A 20211031; JP 2022524814 A 20220510; KR 20210136063 A 20211116; MA 55298 A 20220119; MX 2021010420 A 20211112; TW 202103732 A 20210201; US 2022144945 A1 20220512; UY 38605 A 20200930
DOCDB simple family (application)
US 2020021842 W 20200310; AU 2020234943 A 20200310; BR 112021017644 A 20200310; CA 3133072 A 20200310; CN 202080027211 A 20200310; EP 20717406 A 20200310; IL 28616221 A 20210905; JP 2021554699 A 20200310; KR 20217031856 A 20200310; MA 55298 A 20200310; MX 2021010420 A 20200310; TW 109107890 A 20200310; US 202017437634 A 20200310; UY 38605 A 20200310